NVIDIA Corporation vs Pfizer Inc.: Strategic Comparison
Key Differences at a Glance
| Field | NVIDIA Corporation | Pfizer Inc. |
|---|---|---|
| Revenue | $215.9B | $62.6B |
| Founded | 1993 | 1849 |
| Employees | 42,000 | 75,000 |
| Market Cap | $5.70T | $148.0B |
| Headquarters | United States | United States |
Quick Stats Comparison
| Metric | NVIDIA Corporation | Pfizer Inc. |
|---|---|---|
| Revenue | $215.9B | $62.6B |
| Founded | 1993 | 1849 |
| Headquarters | Santa Clara, California, United States | New York, New York |
| Market Cap | $5.70T | $148.0B |
| Employees | 42,000 | 75,000 |
NVIDIA Corporation Revenue vs Pfizer Inc. Revenue — Year by Year
| Year | NVIDIA Corporation | Pfizer Inc. | Leader |
|---|---|---|---|
| 2026 | $215.9B | N/A | NVIDIA Corporation |
| 2025 | $130.5B | $62.6B | NVIDIA Corporation |
| 2024 | $60.9B | $63.6B | Pfizer Inc. |
| 2023 | N/A | $59.6B | Pfizer Inc. |
| 2022 | N/A | $101.2B | Pfizer Inc. |
Business Model Breakdown
Overview: NVIDIA Corporation vs Pfizer Inc.
This in-depth comparison examines NVIDIA Corporation and Pfizer Inc. across revenue, market value, business model, competitive positioning, and long-term growth strategy. Whether you are researching NVIDIA Corporation on its own, evaluating Pfizer Inc., or weighing the two companies side by side, the breakdown below highlights where each company leads and where the gap between NVIDIA Corporation and Pfizer Inc. is widest.
On the headline numbers, NVIDIA Corporation reports annual revenue of $215.9B against $62.6B for Pfizer Inc., while their respective market capitalizations stand at $5.70T and $148.0B. NVIDIA Corporation is headquartered in United States and Pfizer Inc. operates from United States, and those different home markets shape how each company competes.
NVIDIA Corporation: NVIDIA Corporation is a public company listed on NASDAQ under ticker NVDA. NVIDIA makes money by selling GPUs, AI accelerators, networking systems, systems software, gaming GPUs, professional visualization products, automotive platforms, and cloud/software subscriptions.
Pfizer Inc.: Pfizer has repeatedly reinvented itself around new therapeutic waves, from industrial fermentation and penicillin to Lipitor, vaccines, COVID products, and now oncology. The 2025 profile is not a pandemic windfall story; it is a large pharmaceutical company trying to rebuild a durable growth base.
Business Models: How NVIDIA Corporation and Pfizer Inc. Make Money
NVIDIA Corporation and Pfizer Inc. pursue distinct approaches to generating revenue, and understanding how each company operates is the foundation of any fair comparison between NVIDIA Corporation and Pfizer Inc..
NVIDIA Corporation business model: NVIDIA makes money by selling GPUs, AI accelerators, networking systems, systems software, gaming GPUs, professional visualization products, automotive platforms, and cloud/software subscriptions.
Pfizer Inc. business model: Pfizer makes money from patented prescription medicines, vaccines, oncology products, hospital therapies, rare disease products, collaborations, and global commercial distribution. Its economics depend on R&D success, regulatory approvals, patent protection, reimbursement, and lifecycle management.
Competitive Advantage: NVIDIA Corporation vs Pfizer Inc.
The durability of a company's moat often decides long-term winners. Here is how the competitive advantages of NVIDIA Corporation stack up against those of Pfizer Inc..
NVIDIA Corporation competitive advantage: NVIDIA's advantage is its CUDA software ecosystem, full-stack accelerator roadmap, networking, developer adoption, supply-chain scale, and data center customer pull.
Pfizer Inc. competitive advantage: Pfizer advantage is scale: global regulatory expertise, manufacturing capacity, clinical development experience, commercial infrastructure, vaccine capabilities, and the ability to acquire or partner for scientific platforms.
Growth Strategy: Where NVIDIA Corporation and Pfizer Inc. Are Headed
Future prospects matter as much as current results. The growth strategies below explain how NVIDIA Corporation and Pfizer Inc. each plan to expand from here.
NVIDIA Corporation growth strategy: NVIDIA Corporation's growth strategy centers on this advantage: NVIDIA's advantage is its CUDA software ecosystem, full-stack accelerator roadmap, networking, developer adoption, supply-chain scale, and data center customer pull.
Pfizer Inc. growth strategy: Pfizer growth strategy emphasizes oncology, vaccines, internal medicine, obesity and metabolic research, business development discipline, cost reduction, and global commercial execution. Chris Boshoff became Chief Scientific Officer and President, Research & Development effective January 1, 2025.
Financial Picture: NVIDIA Corporation vs Pfizer Inc.
A closer look at the financial trajectory of NVIDIA Corporation and Pfizer Inc. rounds out the comparison.
NVIDIA Corporation: NVIDIA Corporation reported FY2026 revenue of $215.938B and net income of $120.067B.
Pfizer Inc.: Pfizer reported $62.579 billion of FY2025 revenue, compared with $63.627 billion in FY2024 and $59.553 billion in FY2023. Net income was $7.771 billion in FY2025. Pfizer employed approximately 75,000 people worldwide as of December 31, 2025.
Company-Specific SWOT Notes
NVIDIA Corporation
NVIDIA combines chips, systems, networking, CUDA, libraries, and developer adoption into one AI infrastructure platform.
Large cloud customers and advanced manufacturing partners create concentration and supply-chain risk.
Training, inference, enterprise AI, robotics, sovereign AI, and accelerated computing can expand the addressable market.
Cloud ASICs, rival accelerators, regulation, export restrictions, and capex digestion can slow growth or compress margins.
Pfizer Inc.
Pfizer has manufacturing, regulatory, clinical, and commercial infrastructure that few competitors can match globally.
Major products face loss of exclusivity and pricing pressure, requiring strong replacement revenue.
The Seagen acquisition gives Pfizer a larger oncology platform and ADC pipeline if clinical and commercial execution succeeds.
Medicare negotiation, generic competition, and failed pipeline readouts can compress revenue and margins.
Head-to-Head Scorecard
| Category | Winner | Why |
|---|---|---|
| Revenue Scale | NVIDIA Corporation | NVIDIA Corporation reports the larger revenue base ($215.9B), which serves as a core operational scale signal. |
| Profitability Potential | Comparable | Both organizations prioritize market penetration or are at equivalent reporting tiers. |
| Company Age | Pfizer Inc. | Founded in 1993 vs 1849. The earlier pioneer typically commands longer historical institutional legacy. |
| Innovation Moat | NVIDIA Corporation | Higher aggregate count of major acquisitions and key R&D releases indicates a more active technology absorption velocity. |
| Scale (Employees) | Pfizer Inc. | A significantly larger reported workforce supports enhanced global distribution capability. |
| Market Cap | NVIDIA Corporation | Higher public valuation denotes greater forward-looking investor conviction in earnings potential. |
| Future Outlook | Tied | Strategic auditing assesses that both maintain defensive leadership vectors within their core market clusters. |
Who Wins Each Category?
NVIDIA Corporation reports the larger revenue base ($215.9B), which serves as a core operational scale signal.
Both organizations prioritize market penetration or are at equivalent reporting tiers.
Founded in 1993 vs 1849. The earlier pioneer typically commands longer historical institutional legacy.
Higher aggregate count of major acquisitions and key R&D releases indicates a more active technology absorption velocity.
A significantly larger reported workforce supports enhanced global distribution capability.
Who Wins: NVIDIA Corporation or Pfizer Inc.?
Reviewed by Swet Parvadiya, May 2026 - Author Profile
Our analysts compile business strategy profiles from public financial filings, press releases, and analyst reports. Each profile is reviewed for accuracy before publication by our editorial desk and updated on a rolling basis.
Frequently Asked Questions: NVIDIA Corporation vs Pfizer Inc.
Is NVIDIA Corporation better than Pfizer Inc.?
Verdict: Between NVIDIA Corporation and Pfizer Inc., NVIDIA Corporation is the stronger overall option based on higher annual revenue. The decision still depends on which factors matter most for your needs, but on the weight of the evidence above, NVIDIA Corporation comes out ahead in this NVIDIA Corporation vs Pfizer Inc. comparison.
Who earns more — NVIDIA Corporation or Pfizer Inc.?
NVIDIA Corporation earns more with $215.9B in annual revenue versus Pfizer Inc.'s $62.6B. NVIDIA Corporation leads on total revenue based on latest verified figures.
Which company has higher revenue — NVIDIA Corporation or Pfizer Inc.?
NVIDIA Corporation reported $215.9B, while Pfizer Inc. reported $62.6B. The revenue leader is NVIDIA Corporation based on latest verified figures.
NVIDIA Corporation revenue vs Pfizer Inc. revenue — which is higher?
NVIDIA Corporation revenue: $215.9B. Pfizer Inc. revenue: $62.6B. NVIDIA Corporation has the larger revenue base of the two companies.
Sources & References
- SEC EDGAR: NVIDIA Corporation Annual Filings (10-K, 8-K)
- NVIDIA Corporation Corporate Website
- NVIDIA Corporation Annual Report 2026 - Revenue and Financial Data
- sec.gov
- investor.nvidia.com
- nvidia.com
- SEC EDGAR: Pfizer Inc. Annual Filings (10-K, 8-K)
- Pfizer Inc. Corporate Website
- Pfizer Inc. Annual Report 2025 - Revenue and Financial Data
- sec.gov
- investors.pfizer.com
- pfizer.com
- investors.pfizer.com